five applications before the first yes

yesterday a founder told me his company started with a frozen crayfish.

they froze it using crystal structures made from xenon and water, and brought it back to life twenty four hours later. that experiment turned into a platform, and the platform turned from preservation toward treating the brain... partly because therapeutics are easier to finance.

the company runs mostly on non dilutive government grants. and the part that stuck with me was how they got the first big one.

"the process never works from the first attempt. i would say for alzheimer, we applied maybe five times before we got the grant."

five times.

if your sbir grant just got rejected and you're wondering whether to resubmit, sit with that number. a scientist with a revived crayfish on his resume got told no four times before yes. he said once you're in the system with a good phase one score, it gets easier. the first door is the heavy one.

one practical note if you're in the nih system. their rules allow one resubmission of an application, within 37 months of the first one. so every rejection has to teach you something, because you don't get infinite swings at the same version. the reviewers' comments are the closest thing you'll ever get to a free diligence report. read them like a map.

then he told me about the second wall, and it was a different shape.

his lead indication is opioid use disorder, about three years to market. the science is strong. the investor reaction has been weak. in his words, "we had a very limited following because it's probably a significant stigma around it."

nobody said the data was bad. they flinched at the word.

so he's reconsidering the frame. same molecule, same trials... but positioned as preventing opioid addiction rather than treating it. one version sounds like a problem people want to look away from. the other sounds like protecting someone before the problem starts.

that's the lesson in both stories. keep the science. change the frame.

grant reviewers and investors are both human. they're reading fast, comparing you to a stack of others, and reacting to words before they react to data. a rejection is often a framing problem wearing a science costume.

it's like a great song with the wrong title. the music doesn't change, but suddenly people press play.

there was one more thing in that conversation that worries me for a lot of founders. he was paying two outreach vendors at the same time, one on linkedin and one on email, and seeing no meaningful response from investors.

two machines, both pushing the same frame that wasn't landing. more volume on a message that makes people flinch just gets you more flinching.

before you buy more reach, test the frame. send the treatment version to twenty people and the prevention version to twenty more. let the replies tell you which story the market wants to hear.

and notice he didn't touch the molecule to fix either problem. the grant got better with each rewrite. the investor story is getting a new frame. the science stayed stubborn the whole time.

long term, the founders who make it in hard science aren't the ones who never get rejected. they're the ones who treat every no as data about the frame, and keep showing up with the same stubborn science underneath.

i keep a running list of the things i check before a founder goes out to raise in the founder's fundraising checklist. frame testing is near the top.

so how many times have you applied, pitched, or asked... and how many times did you change the frame before you asked again?